Endava is trading at $1.72, down 5.25% on September 28 as U.S. stocks face risk-off pressure alongside rising oil prices and bond yields. - Reuters reported weaker Wall Street futures amid inflation concerns and the U.S.-Iran standoff. - No fresh Endava-specific catalyst was identified. Investors may still be weighing the recent CFO leave, accounting investigation and delayed reports disclosed in coverage dated September 25; these are background, not a confirmed cause of today’s move.